These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18685357)

  • 1. Predicting outcomes in patients with urologic cancers.
    Karakiewicz PI; Hutterer GC
    Curr Opin Support Palliat Care; 2007 Oct; 1(3):153-68. PubMed ID: 18685357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness research in urologic cancers.
    Strope SA
    Cancer Treat Res; 2015; 164():221-35. PubMed ID: 25677026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urologic malignancies in renal transplant candidates and recipients].
    Kleinclauss F; Thuret R; Murez T; Timsit MO
    Prog Urol; 2016 Nov; 26(15):1094-1113. PubMed ID: 27665407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of imaging in the surveillance of urologic malignancies.
    Bradford TJ; Montie JE; Hafez KS
    Urol Clin North Am; 2006 Aug; 33(3):377-96. PubMed ID: 16829272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External validation of preoperative and postoperative nomograms for prediction of cancer-specific survival, overall survival and recurrence after robot-assisted radical cystectomy for urothelial carcinoma of the bladder.
    Al-Daghmin A; English S; Kauffman EC; Din R; Khan A; Syed JR; Sztorc J; Mehedint D; Sharif M; Shi Y; Wilding G; Guru KA
    BJU Int; 2014 Aug; 114(2):253-60. PubMed ID: 24119175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining oligometastatic state in uro-oncological cancers.
    Fazekas T; Miszczyk M; Matsukawa A; Nyirády P; Shariat SF; Rajwa P
    Curr Opin Urol; 2024 Jul; 34(4):261-265. PubMed ID: 38704827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of C-reactive protein in urological cancers: a useful biomarker for predicting outcomes.
    Saito K; Kihara K
    Int J Urol; 2013 Feb; 20(2):161-71. PubMed ID: 22897628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urologic Pathology: Key Parameters from a Urologist's Perspective.
    Borchert A; Rogers CG
    Surg Pathol Clin; 2018 Dec; 11(4):893-901. PubMed ID: 30447847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical innovations in urologic oncology.
    Williams RD
    Int J Urol; 1996 Jan; 3(1 Suppl):S40. PubMed ID: 24304020
    [No Abstract]   [Full Text] [Related]  

  • 10. [News with clinical relevance from major scientific meetings 2014 - Update Urooncology].
    Hegele A; Skrobek L; Boegemann M
    Aktuelle Urol; 2015 Mar; 46(2):106-17. PubMed ID: 25909966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urological tumours: recent changes.
    Gardiner RA
    Aust N Z J Surg; 1995 May; 65(5):350-8. PubMed ID: 7537956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and isolation of circulating tumor cells in urologic cancers: a review.
    Loberg RD; Fridman Y; Pienta BA; Keller ET; McCauley LK; Taichman RS; Pienta KJ
    Neoplasia; 2004; 6(4):302-9. PubMed ID: 15256052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role for metformin in urologic oncology.
    Sayyid RK; Fleshner NE
    Investig Clin Urol; 2016 May; 57(3):157-64. PubMed ID: 27195314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Update urooncology: news with clinical relevance from major scientific meetings 2012].
    Hegele A; Skrobek L; Schrader AJ
    Aktuelle Urol; 2012 Dec; 43(6):376-87. PubMed ID: 23254351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary urological cancers in a context of limited resources: Epidemiology and treatment].
    Ouedraogo S; Traore MT; Kambire JL; Ouedraogo S; Bere B; Kabore AF
    Bull Cancer; 2019 Oct; 106(10):868-874. PubMed ID: 31350015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Update uro-oncology: scientific meetings 2011].
    Hegele A; Skrobek L; Schrader AJ
    Aktuelle Urol; 2012 Jan; 43(1):13-27. PubMed ID: 22344822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis.
    Yao X; Liu H; Xu H
    Biomed Res Int; 2021; 2021():5311828. PubMed ID: 34660791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Response criteria for urological cancer treatment].
    Nihon Hinyokika Gakkai Zasshi; 1992 Apr; 83(4):447-72. PubMed ID: 1593826
    [No Abstract]   [Full Text] [Related]  

  • 19. Trends in palliative care interventions among patients with advanced bladder, prostate, or kidney cancer: A retrospective cohort study.
    Lec PM; Lenis AT; Brisbane W; Sharma V; Golla V; Gollapudi K; Blumberg J; Drakaki A; Bergman J; Chamie K
    Urol Oncol; 2020 Nov; 38(11):854.e1-854.e9. PubMed ID: 32430252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of nomograms as predictive tools in bladder cancer.
    Shabsigh A; Bochner BH
    World J Urol; 2006 Nov; 24(5):489-98. PubMed ID: 17077975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.